Regeneron at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
Regeneron takes part in 3 sessions at Antibody Engineering 2026 in San Diego. Its program spans dose selection for new biologics, antibodies against hard-to-reach targets such as IgE responses, and antibodies that bind three or more targets. The dose work follows a molecule from its design through to an approved treatment regimen.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Regeneron Tarrytown, NY | |
Biotechnology company that discovers, develops and markets antibody medicines, including bispecific antibodies, using its VelocImmune mouse platform. | Talk Sun Dec 13 3:45pm–4:15pm From Molecule Design to Approved Regimens: A Clinical Pharmacology Perspective on Dose Selection for Next-Generation Biologics How measurements of drug levels and effects in the body guide the first human dose and the final approved dosing schedule. Talk Mon Dec 14 5:15pm–5:45pm Targeting IgE Responses Beyond oncology Chair Wed Dec 16 8:10am–8:15am |
Find decision makers at Regeneron
Tell us what you sell and we’ll find the people at Regeneron most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction